SEI Investments’s ALX Oncology ALXO Stock Holding History

SEI Investments’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,795	Closed	-$37.9K	–	2789
2025 Q1	$37.9K	Hold	60,795	–	–	﹤0.01%	2697
2024 Q4	$102K	Buy	+60,795	New	+$93.5K	﹤0.01%	2581

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SEI Investments's ALXO Position: Q2 2025 in Review

SEI Investments sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 60,795 shares — an estimated $37.9K sold.

SEI Investments first reported a position in ALXO in Q4 2024 and held it in 2 quarters. The position peaked at $102K in Q4 2024. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

SEI Investments reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
SEI Investments sold 60,795 ALX Oncology shares in Q2 2025, an estimated $37.9K.
SEI Investments first reported a position in ALX Oncology in Q4 2024 and held it in 2 quarters.
SEI Investments's ALX Oncology position peaked at $102K in Q4 2024.
61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on SEI Investments's 13F filing for Q2 2025, filed 14 Aug 2025.